Luzzi R - Search Results

1

Statistical thermodynamics of the Fröhlich-Bose-Einstein condensation of magnons out of equilibrium.

Vannucchi FS, Luzzi R. Vannucchi FS, et al. Among authors: luzzi r. Phys Rev E. 2019 Sep;100(3-1):032126. doi: 10.1103/PhysRevE.100.032126. Phys Rev E. 2019. PMID: 31639996

2

Microscopic approach to irreversible thermodynamics. I. General theory.

Vasconcellos ÁR, Luzzi R, García-Colin LS. Vasconcellos ÁR, et al. Among authors: luzzi r. Phys Rev A. 1991 Jun 15;43(12):6622-6632. doi: 10.1103/physreva.43.6622. Phys Rev A. 1991. PMID: 9905014 No abstract available.

3

Microscopic approach to irreversible thermodynamics. II. An example from semiconductor physics.

Vasconcellos ÁR, Luzzi R, Garca-Colin LS. Vasconcellos ÁR, et al. Among authors: luzzi r. Phys Rev A. 1991 Jun 15;43(12):6633-6641. doi: 10.1103/physreva.43.6633. Phys Rev A. 1991. PMID: 9905015 No abstract available.

4

Primary benign back pain: supplementation with Pycnogenol®.

Cox D, Belcaro G, Cesarone MR, Cotellese R, Dugall M, Feragalli B, Hosoi M, Corsi M, Luzzi R. Cox D, et al. Among authors: luzzi r. Panminerva Med. 2021 Dec;63(4):472-477. doi: 10.23736/S0031-0808.20.03961-0. Panminerva Med. 2021. PMID: 34915691

5

Pycnogenol® supplementation prevents inflammation and symptoms in recurrent, non-severe urinary infections.

Cotellese R, Hu S, Cesarone MR, Belcaro G, Dugall M, Feragalli B, Hosoi M, Ippolito E, Corsi M, Luzzi R. Cotellese R, et al. Among authors: luzzi r. Panminerva Med. 2021 Sep;63(3):343-348. doi: 10.23736/S0031-0808.20.03853-7. Panminerva Med. 2021. PMID: 34738775

6

Pycnogenol® Supplementation Prevents Recurrent Urinary Tract Infections/Inflammation and Interstitial Cystitis.

Ledda A, Hu S, Cesarone MR, Belcaro G, Dugall M, Feragalli B, Cotellese R, Hosoi M, Ippolito E, Corsi M, Luzzi R. Ledda A, et al. Among authors: luzzi r. Evid Based Complement Alternat Med. 2021 Jun 23;2021:9976299. doi: 10.1155/2021/9976299. eCollection 2021. Evid Based Complement Alternat Med. 2021. PMID: 34257695 Free PMC article.

7

Pycnogenol®+Centellicum®, post-stent evaluation: prevention of neointima and plaque re-growth.

Belcaro G, Cesarone MR, Scipione C, Scipione V, Dugall M, Hu S, Feragalli B, Luzzi R, Hosoi M, Maione C, Cotellese R. Belcaro G, et al. Among authors: luzzi r. Minerva Cardioangiol. 2019 Dec;67(6):450-455. doi: 10.23736/S0026-4725.19.05048-5. Minerva Cardioangiol. 2019. PMID: 31850725

8

Management of mild, primary Raynaud Syndrome: supplementation with Pycnogenol®.

Hu S, Hosoi M, Belcaro G, Dugall M, Feragalli B, Cotellese R, Luzzi R. Hu S, et al. Among authors: luzzi r. Minerva Cardioangiol. 2019 Oct;67(5):392-398. doi: 10.23736/S0026-4725.19.04991-0. Minerva Cardioangiol. 2019. PMID: 31637898

9

Delayed progression of atherosclerosis and cardiovascular events in asymptomatic patients with atherosclerotic plaques: 3-year prevention with the supplementation with Pycnogenol®+Centellicum®.

Belcaro G, Cesarone MR, Scipione C, Scipione V, Dugall M, Shu H, Peterzan P, Corsi M, Luzzi R, Hosoi M, Feragalli B, Cotellese R. Belcaro G, et al. Among authors: luzzi r. Minerva Cardioangiol. 2020 Feb;68(1):15-21. doi: 10.23736/S0026-4725.19.05051-5. Epub 2019 Oct 11. Minerva Cardioangiol. 2020. PMID: 31625707

10

Pycnogenol®: supplementary management of symptomatic osteoarthritis with a patch. An observational registry study.

Feragalli B, Dugall M, Luzzi R, Ledda A, Hosoi M, Belcaro G, Cesarone MR. Feragalli B, et al. Among authors: luzzi r. Minerva Endocrinol. 2019 Mar;44(1):97-101. doi: 10.23736/S0391-1977.18.02820-1. Minerva Endocrinol. 2019. PMID: 30561176

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results